Filing Details
- Accession Number:
- 0001140361-17-019043
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-09 13:23:06
- Reporting Period:
- 2017-05-05
- Filing Date:
- 2017-05-09
- Accepted Time:
- 2017-05-09 13:23:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557533 | Robert Jeffrey Ajer | C/O Biomarin Pharmaceutical Inc., 105 Digital Drive Novato CA 94949 | Evp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-05 | 988 | $28.23 | 52,520 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-05 | 988 | $99.00 | 51,532 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-05-05 | 3,498 | $38.59 | 55,030 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-05 | 3,498 | $99.00 | 51,532 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2017-05-05 | 988 | $0.00 | 988 | $28.23 |
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2017-05-05 | 3,498 | $0.00 | 3,498 | $38.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-12-01 | 2021-05-30 | No | 4 | M | Direct |
| 0 | 2008-11-22 | 2018-05-21 | No | 4 | M | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.
- All shares were sold at the same price.
- Reflects the number of stock options outstanding after the transaction from this specific stock option grant.
Billionaire Hedge Funds
